Border Medical Oncology

Albury

0 studies enrolling now · 2 studies all time

What they study most

HER2 Exon 20 Mutation, Lung Cancer, Non Small Cell Lung Cancer, Non-squamous NSCLC, Nonsquamous Non Small Cell Lung Cancer, Squamous Non Small Cell Lung Cancer

Studies at this site

• Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer — Completed
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed